SBC MEDICAL GROUP HOLDINGS I (SBC) Fundamental Analysis & Valuation
NASDAQ:SBC • US73245B1070
Current stock price
3.31 USD
+0.01 (+0.3%)
At close:
3.37 USD
+0.06 (+1.81%)
After Hours:
This SBC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. SBC Profitability Analysis
1.1 Basic Checks
- In the past year SBC was profitable.
- SBC had a positive operating cash flow in the past year.
- SBC had positive earnings in 4 of the past 5 years.
- The reported operating cash flow has been mixed in the past 5 years: SBC reported negative operating cash flow in multiple years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 13.40%, SBC belongs to the top of the industry, outperforming 98.00% of the companies in the same industry.
- SBC has a Return On Equity of 20.54%. This is amongst the best in the industry. SBC outperforms 90.00% of its industry peers.
- SBC has a better Return On Invested Capital (13.29%) than 90.00% of its industry peers.
- SBC had an Average Return On Invested Capital over the past 3 years of 22.12%. This is significantly above the industry average of 8.40%.
- The 3 year average ROIC (22.12%) for SBC is well above the current ROIC(13.29%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.4% | ||
| ROE | 20.54% | ||
| ROIC | 13.29% |
ROA(3y)15.38%
ROA(5y)N/A
ROE(3y)24.04%
ROE(5y)N/A
ROIC(3y)22.12%
ROIC(5y)N/A
1.3 Margins
- SBC has a Profit Margin of 29.37%. This is amongst the best in the industry. SBC outperforms 100.00% of its industry peers.
- SBC has a Operating Margin of 38.87%. This is amongst the best in the industry. SBC outperforms 100.00% of its industry peers.
- Looking at the Gross Margin, with a value of 73.32%, SBC belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 38.87% | ||
| PM (TTM) | 29.37% | ||
| GM | 73.32% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. SBC Health Analysis
2.1 Basic Checks
- SBC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for SBC remains at a similar level compared to 1 year ago.
- Compared to 1 year ago, SBC has a worse debt to assets ratio.
2.2 Solvency
- SBC has an Altman-Z score of 4.00. This indicates that SBC is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of SBC (4.00) is better than 77.00% of its industry peers.
- The Debt to FCF ratio of SBC is 1.93, which is an excellent value as it means it would take SBC, only 1.93 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 1.93, SBC is in the better half of the industry, outperforming 77.00% of the companies in the same industry.
- A Debt/Equity ratio of 0.14 indicates that SBC is not too dependend on debt financing.
- SBC has a Debt to Equity ratio of 0.14. This is in the better half of the industry: SBC outperforms 72.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 1.93 | ||
| Altman-Z | 4 |
ROIC/WACC1.55
WACC8.55%
2.3 Liquidity
- A Current Ratio of 3.78 indicates that SBC has no problem at all paying its short term obligations.
- SBC has a better Current ratio (3.78) than 89.00% of its industry peers.
- A Quick Ratio of 3.74 indicates that SBC has no problem at all paying its short term obligations.
- SBC has a better Quick ratio (3.74) than 89.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.78 | ||
| Quick Ratio | 3.74 |
3. SBC Growth Analysis
3.1 Past
- SBC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.81%, which is quite good.
- SBC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 131.30% yearly.
- The Revenue for SBC has decreased by -15.48% in the past year. This is quite bad
EPS 1Y (TTM)19.81%
EPS 3Y131.3%
EPS 5YN/A
EPS Q2Q%-26.32%
Revenue 1Y (TTM)-15.48%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.93%
3.2 Future
- The Earnings Per Share is expected to grow by 1.01% on average over the next years.
- SBC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.52% yearly.
EPS Next Y-9.99%
EPS Next 2Y0.5%
EPS Next 3Y1.01%
EPS Next 5YN/A
Revenue Next Year-0.06%
Revenue Next 2Y4.22%
Revenue Next 3Y3.52%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. SBC Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 6.76 indicates a rather cheap valuation of SBC.
- 97.00% of the companies in the same industry are more expensive than SBC, based on the Price/Earnings ratio.
- SBC is valuated cheaply when we compare the Price/Earnings ratio to 26.64, which is the current average of the S&P500 Index.
- The Price/Forward Earnings ratio is 7.51, which indicates a rather cheap valuation of SBC.
- Based on the Price/Forward Earnings ratio, SBC is valued cheaply inside the industry as 96.00% of the companies are valued more expensively.
- SBC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.76 | ||
| Fwd PE | 7.51 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SBC indicates a rather cheap valuation: SBC is cheaper than 98.00% of the companies listed in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of SBC indicates a somewhat cheap valuation: SBC is cheaper than 73.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.23 | ||
| EV/EBITDA | 3.1 |
4.3 Compensation for Growth
- SBC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.5%
EPS Next 3Y1.01%
5. SBC Dividend Analysis
5.1 Amount
- SBC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
SBC Fundamentals: All Metrics, Ratios and Statistics
3.31
+0.01 (+0.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength49.07
Industry Growth86.96
Earnings (Last)03-27 2026-03-27/bmo
Earnings (Next)05-14 2026-05-14
Inst Owners1.3%
Inst Owner ChangeN/A
Ins Owners85.22%
Ins Owner Change-3.91%
Market Cap339.54M
Revenue(TTM)173.61M
Net Income(TTM)50.99M
Analysts82.86
Price Target8.41 (154.08%)
Short Float %2.23%
Short Ratio4.7
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.76%
Min EPS beat(2)8.01%
Max EPS beat(2)15.51%
EPS beat(4)3
Avg EPS beat(4)6.8%
Min EPS beat(4)-85.33%
Max EPS beat(4)89.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.97%
Min Revenue beat(2)-13.79%
Max Revenue beat(2)-4.16%
Revenue beat(4)0
Avg Revenue beat(4)-7.74%
Min Revenue beat(4)-13.79%
Max Revenue beat(4)-3.99%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.51%
PT rev (3m)-0.51%
EPS NQ rev (1m)-2%
EPS NQ rev (3m)-2%
EPS NY rev (1m)-11.78%
EPS NY rev (3m)-11.78%
Revenue NQ rev (1m)-5.66%
Revenue NQ rev (3m)-7.65%
Revenue NY rev (1m)-5.12%
Revenue NY rev (3m)-6.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.76 | ||
| Fwd PE | 7.51 | ||
| P/S | 1.96 | ||
| P/FCF | 15.23 | ||
| P/OCF | 13.76 | ||
| P/B | 1.37 | ||
| P/tB | 1.83 | ||
| EV/EBITDA | 3.1 |
EPS(TTM)0.49
EY14.8%
EPS(NY)0.44
Fwd EY13.32%
FCF(TTM)0.22
FCFY6.57%
OCF(TTM)0.24
OCFY7.27%
SpS1.69
BVpS2.42
TBVpS1.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.16572 (56.06%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.4% | ||
| ROE | 20.54% | ||
| ROCE | 21.13% | ||
| ROIC | 13.29% | ||
| ROICexc | 27.34% | ||
| ROICexgc | 46.1% | ||
| OM | 38.87% | ||
| PM (TTM) | 29.37% | ||
| GM | 73.32% | ||
| FCFM | 12.84% |
ROA(3y)15.38%
ROA(5y)N/A
ROE(3y)24.04%
ROE(5y)N/A
ROIC(3y)22.12%
ROIC(5y)N/A
ROICexc(3y)40.49%
ROICexc(5y)N/A
ROICexgc(3y)50.1%
ROICexgc(5y)N/A
ROCE(3y)35.17%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 1.93 | ||
| Debt/EBITDA | 0.48 | ||
| Cap/Depr | 88.29% | ||
| Cap/Sales | 1.37% | ||
| Interest Coverage | 420.21 | ||
| Cash Conversion | 35.16% | ||
| Profit Quality | 43.74% | ||
| Current Ratio | 3.78 | ||
| Quick Ratio | 3.74 | ||
| Altman-Z | 4 |
F-Score4
WACC8.55%
ROIC/WACC1.55
Cap/Depr(3y)89.84%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.94%
Cap/Sales(5y)N/A
Profit Quality(3y)60.27%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.81%
EPS 3Y131.3%
EPS 5YN/A
EPS Q2Q%-26.32%
EPS Next Y-9.99%
EPS Next 2Y0.5%
EPS Next 3Y1.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.48%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.93%
Revenue Next Year-0.06%
Revenue Next 2Y4.22%
Revenue Next 3Y3.52%
Revenue Next 5YN/A
EBIT growth 1Y-20.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2.19%
EBIT Next 3Y3.82%
EBIT Next 5YN/A
FCF growth 1Y29.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.85%
OCF growth 3YN/A
OCF growth 5YN/A
SBC MEDICAL GROUP HOLDINGS I / SBC Fundamental Analysis FAQ
What is the fundamental rating for SBC stock?
ChartMill assigns a fundamental rating of 6 / 10 to SBC.
Can you provide the valuation status for SBC MEDICAL GROUP HOLDINGS I?
ChartMill assigns a valuation rating of 7 / 10 to SBC MEDICAL GROUP HOLDINGS I (SBC). This can be considered as Undervalued.
Can you provide the profitability details for SBC MEDICAL GROUP HOLDINGS I?
SBC MEDICAL GROUP HOLDINGS I (SBC) has a profitability rating of 7 / 10.
What are the PE and PB ratios of SBC MEDICAL GROUP HOLDINGS I (SBC) stock?
The Price/Earnings (PE) ratio for SBC MEDICAL GROUP HOLDINGS I (SBC) is 6.76 and the Price/Book (PB) ratio is 1.37.
Can you provide the expected EPS growth for SBC stock?
The Earnings per Share (EPS) of SBC MEDICAL GROUP HOLDINGS I (SBC) is expected to decline by -9.99% in the next year.